Very early withdrawal from treatment in patients starting peritoneal dialysis.

about

Very early withdrawal from treatment in patients starting peritoneal dialysis.

Item

http://www.wikidata.org/entity/Q47181152

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Very early withdrawal from treatment in patients starting peritoneal dialysis.

@en

Very early withdrawal from treatment in patients starting peritoneal dialysis.

@nl

type

Item

label

Very early withdrawal from treatment in patients starting peritoneal dialysis.

@en

Very early withdrawal from treatment in patients starting peritoneal dialysis.

@nl

prefLabel

Very early withdrawal from treatment in patients starting peritoneal dialysis.

@en

Very early withdrawal from treatment in patients starting peritoneal dialysis.

@nl

P1476

Very early withdrawal from treatment in patients starting peritoneal dialysis.

@en

P2093

Fengxian Huang

http://www.w3.org/2001/XMLSchema#string

Jianxiong Lin

http://www.w3.org/2001/XMLSchema#string

Qimei Luo

http://www.w3.org/2001/XMLSchema#string

Xi Xia

http://www.w3.org/2001/XMLSchema#string

Xiao Yang

http://www.w3.org/2001/XMLSchema#string

Xueqing Yu

http://www.w3.org/2001/XMLSchema#string

Zhenchuan Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Living with encapsulating peritoneal sclerosis (EPS): the patient's perspective

Outcomes of a peritoneal dialysis program in remote communities within Colombia.

Comparison of the impact of "fast decline" in residual renal function and "initial anuria" on long-term outcomes in CAPD patients.

The risk factors and the impact of hernia development on technique survival in peritoneal dialysis patients: a population-based cohort study.

Cholesterol Metabolism in CKD

Reduced residual renal function is associated with endothelial dysfunction in patients receiving peritoneal dialysis.

Nephrology in china.

Worldwide access to treatment for end-stage kidney disease: a systematic review.

Is high high-density lipoprotein cholesterol beneficial for premature coronary heart disease? A meta-analysis.

High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study.

P304

8-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0886022X.2017.1419965

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29297246

http://www.w3.org/2001/XMLSchema#string

P932

6014309

http://www.w3.org/2001/XMLSchema#string